Viewing nowCombinationAmoizartan Q Tablets 5/50/20 mg (Amlodipine, Losartan, Rosuvastatin)
Amlodipine Camsylate 7.84mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 201705689 · Approved 2017.07.14 · Insurance code 643507840
Treatment of hypertension and dyslipidemia; inhibition of atherosclerosis progression and reduction of cardiovascular risk
This medication is used as a first-line treatment for patients with essential hypertension whose blood pressure is not well controlled with either amlodipine or losartan alone or for patients with stage 2 hypertension who need combination therapy to reach their target blood pressure. Moreover, the rosuvastatin component is effective as an adjunct therapy in patients with primary hypercholesterolemia and mixed hyperlipidemia who are difficult to manage with diet and exercise alone. This medication also acts as an adjunct to dietary therapy for patients with homozygous familial hypercholesterolemia or dysbetalipoproteinemia, lowering total cholesterol and LDL cholesterol levels, thereby slowing the progression of atherosclerosis. Particularly, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in patients at high risk for cardiovascular diseases. Overall, this medication is used to manage both blood pressure and cholesterol levels simultaneously to improve cardiovascular health.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/losartan combination and rosuvastatin. ○ Amlodipine/losartan combination The recommended dose of the amlodipine/losartan combination is 1 tablet once daily in adults, taken with water, with or without food. If possible, it is recommended that the medicine be taken at the same time each day (e.g., in the morning). Before starting the amlodipine/losartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not adequately controlled with monotherapy using either individual component, switching directly to the amlodipine/losartan combination may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Before using the amlodipine/losartan combination as initial therapy in patients with stage 2 hypertension, the decision to use it should take into account baseline blood pressure, the target blood pressure, and the expected extent to which the combination may achieve the treatment goal compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ∘ Patients with renal impairment: Dose adjustment is not required in patients with mild renal impairment (e.g., creatinine clearance 20∼50mL/min), but use of the amlodipine/losartan combination is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ∘ Patients with reduced effective intravascular volume: Use of the amlodipine/losartan combination is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients receiving treatment with high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of the amlodipine/losartan combination is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ∘ Older patients: In older patients aged 75 years or over, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of the amlodipine/losartan combination as initial therapy is not recommended. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during rosuvastatin treatment and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose in adults is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg once daily. 2. Older patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with use in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Use of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Use of the rosuvastatin 40 mg dose is contraindicated in some of these patients. Patients taking the amlodipine/losartan combination and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can cause serious harm to the fetus if taken during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Caution is especially needed during the second and third trimesters due to risks such as impaired fetal kidney function, skeletal malformations, and decreased lung development. In patients with low blood volume, adverse effects such as hypotension may occur, so their condition should be stabilized before starting the medication. Patients with allergies to any components of this medication or specific liver or kidney diseases, and those with severe muscular disorders should avoid taking it. Caution is required for elderly patients, those with impaired liver function, and patients with hyperkalemia when using this medication, and those with low blood pressure should also pay attention. This medication can cause serious muscle-related side effects such as myalgia, myopathy, and rarely, rhabdomyolysis, so if muscle pain or weakness occurs, consult a physician immediately. Regular blood tests and liver function tests are necessary as liver or kidney function impairments may occur. Interactions may occur when taken with other drugs, so you must inform healthcare providers of any medications being taken. Special caution is needed when combined with potassium-sparing diuretics, potassium supplements, certain antibiotics, antifungals, and immunosuppressants. This medication is not recommended for breastfeeding women and women of childbearing potential should use appropriate contraception. Dizziness or low blood pressure may occur during treatment, so caution is needed when driving or operating machinery. If any abnormal symptoms appear during the medication period, immediate consultation with healthcare professionals is necessary for appropriate action.
Upper respiratory tract infection, dizziness, dyspepsia, lower gastrointestinal bleeding, orthostatic dizziness, syncope, rhabdomyolysis, pancreatic malignancy, dizziness, headache, drowsiness, cerebral infarction, fatigue, chest discomfort, chest pain, early satiety, peripheral edema, pitting edema, abdominal discomfort, nausea, gastroesophageal reflux disease, constipation, pruritus, urticaria, palpitations, flushing, orthostatic hypotension, facial flushing, dyspnea, cough, conjunctival injection, frequent urination, angioedema, diabetes, constipation, nausea, abdominal pain, pancreatitis, rash, myalgia, myopathy, fatigue, polyneuropathy, amnesia, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, eosinophilia and systemic symptoms associated drug reaction syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, ALT elevation, chest pain, myalgia, CK elevation, fatigue, arthralgia, tiredness, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, vasculitis, tension increase, sensory loss, peripheral neuropathy, taste disturbance, tremor, extrapyramidal disorder, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, dyspepsia, gingival hyperplasia, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, leukopenia, thrombocytopenia, insomnia, mood changes, rhinitis, hair loss, hyperhidrosis, purpura, skin discoloration, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, urinary disorders, nocturia, hepatitis, jaundice, liver enzyme elevation, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, blood pressure drop, sinus node block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, cutaneous erythema, maculopapular rash, heaviness, warmth, impaired glucose tolerance, weakness, facial rash, lip swelling, angioedema, lip swelling, facial rash, vasculitis, symptoms resembling anaphylaxis, fatigue, anemia, thrombocytopenia, taste disturbance, dry cough, erythema, hyperkalemia, hyponatremia, acute renal failure, oliguria, thrombocytopenia, increased serum creatinine level, headache, dizziness, ALT elevation, CK elevation, constipation, AST elevation, fatigue, arthralgia, tiredness, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, angioedema, vasculitis, tension increase, sensory loss, peripheral neuropathy, taste disturbance, tremor, extrapyramidal disorder, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, dyspepsia, gingival hyperplasia, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, leukopenia, thrombocytopenia, insomnia, mood changes, rhinitis, hair loss, hyperhidrosis, purpura, skin discoloration, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, urinary disorders, nocturia, hepatitis, jaundice, liver enzyme elevation, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, blood pressure drop, sinus node block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, cutaneous erythema, maculopapular rash, heaviness, warmth, impaired glucose tolerance, weakness, facial rash, lip swelling, angioedema, lip swelling, facial rash, vasculitis, symptoms resembling anaphylaxis, fatigue, anemia, thrombocytopenia, taste disturbance, dry cough, erythema, hyperkalemia, hyponatremia, acute renal failure, oliguria, thrombocytopenia, increased serum creatinine level
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This ensures that the effectiveness of the medication is preserved for a long time and can be used safely.
Yellow oval film-coated tablets
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 5.2mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 5.2mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.